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The laminin a4 chain, a component of laminin-8/9, is expressed in basement membranes of endothelial cells, the
peripheral nerves, and muscle ﬁbers. The localization and functions of laminin a4 chain in the skin have not been
elucidated. By immunostaining with speciﬁc antibodies, we demonstrate here that the a4 chain is located in the
basement membrane zones of blood vessels and is also associated with ﬁbroblast-like cells in the dermis. Western
blot showed that cultured ﬁbroblasts secreted a laminin trimer containing the a4 chain. We have also focused on
the cell adhesion activities of the human laminin a4 LG4 module since the corresponding LG4 module of laminin a3
was previously identiﬁed as active for cell adhesion. Recombinant human a4 LG4 was active for heparin-dependent
ﬁbroblast adhesion. Screening assays with 19 synthetic peptides covering the entire a4 LG4 module identiﬁed
three peptides (HA4G82: TLFLAHGRLVYM; HA4G83: LVYMFNVGHKKL; and HA4G90: TEATWKIKGPIYL) as active
sites for heparin- and heparan sulfate-dependent cell adhesion. Serine-substituted peptides demonstrated that two
basic residues, His and Arg, within HA4G82 were essential for cell adhesion activity. The cell surface heparan
sulfate proteoglycans (HSPGs), syndecan-2, -4, and glypican-1, were stably expressed in 293T cells to estimate
whether they function as cell adhesion receptors. 293T cells overexpressing syndecan-2 or -4 bound to
recombinant a4 LG4 and to HA4G82, but parental or glypican-1-overexpressing 293T cells did not. Therefore,
syndecan-2 and -4 could mediate cell adhesion to the laminin a4 LG4 module. Our study suggests that the laminin
a4 LG4 module may play an important role in cell adhesion and/or vessel wall formation in the skin by interacting
with syndecan-2 and/or -4.
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Laminins are a large family of heterotrimeric extracellular
matrix glycoproteins in the basement membrane that
promote cell adhesion, migration, differentiation, prolifera-
tion, angiogenesis, and tumor invasion (Timpl, 1996). In
mammals, five different a chains, three b chains, and three g
chains have been identified that assemble into 15 different
heterotrimeric combinations (laminin-1–15). Three chains
assemble into a cross-shaped heterotrimer (abg) through
coiled-coil interactions at the long arm of the cross (Utani
et al, 1994, 1995).
The laminin a4 chain (200 kDa) is the shortest variant and
is present in laminin-8 (a4b1g1) and in laminin-9 (a4b2g1)
(Miner et al, 1997). The laminin a4 chain is widely distributed
both in adults and during development in tissues, such as
cardiac skeletal and smooth muscle fibers, vascular endo-
thelia, lungs, and peripheral nerves. The a4 chain is also
weakly expressed in other adult tissues, such as the brain,
spleen, liver, kidney, and testis (Iivanainen et al, 1997;
Patton et al, 1997). Analysis of the a4-null mouse demon-
strated bleeding during the embryonic and neonatal periods
and impaired microvessel growth in experimental angiogen-
esis (Thyboll et al, 2002). Histological examination showed
structurally abnormal capillary basement membranes in the
null mice (Thyboll et al, 2002). These data indicate that the
laminin a4 chain is involved in stable basement membrane
assembly in blood vessels.
The laminin a chains contain a large C-terminal globular
domain (G domain), which is composed of five tandem
homologous modules (LG1–5) of about 200 amino acids
(Talts et al, 1998). Laminin-8 (a4b1g1) binds to a6b1 and
a3b1 integrins (Geberhiwot et al, 1999; Kortesmaa et al,
2000; Fujiwara et al, 2001). The mouse laminin a4 chain G
domain binds to heparin and the LG4 module of the a4
chain is critical for the heparin binding (Yamaguchi et al,
2000). The mouse laminin a4 chain G domain promotes cell
adhesion through binding to integrins and syndecans
(Okazaki et al, 2002). The LG4 module of the a5 chain
showed heparin-dependent cell adhesion activity (Nielsen
et al, 2000). Moreover, syndecans bound to the laminin a3
chain LG4 module and functioned as cell adhesion recept-
ors (Utani et al, 2001). We also demonstrated that the a3
chain LG4 module induces matrix metalloproteinase-1
expression through mitogen-activated protein kinase acti-
vation (Utani et al, 2003). These observations indicate the
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biological importance of the C-terminal G domain of laminin
a chains, especially LG4 modules.
Localization of the laminin a4 chain in the skin has not
been examined. In this study, we have demonstrated
localization of human laminin a4 chain in the skin, where it
is associated with fibroblast-like cells in the dermis. The
synthesis of laminin a4 chain by dermal fibroblasts has been
demonstrated. We also showed that dermal fibroblasts
attached to laminin a4 LG4 in a heparin-dependent manner.
Results
Distribution of laminin a4 in the skin and its synthesis in
the dermal ﬁbroblasts Laminin a4 chain has a tandem
repeat of five LG modules, LG1–5, at the C-terminus.
Processing of the a4 LG4–5 module is known to occur in
tissues and in cultured cells. Thus, we used two antibodies
for immunostaining, anti-a4 LG1–3 and anti-a4 LG4–5
antibodies, which recognize different modules (Fig 1A).
Using frozen human skin sections, both antibodies gave
similar results and stained the basement membrane zones
of blood vessels and fibroblast-like cells in the dermis.
Thus, both the unprocessed and processed laminin a4
chains are localized in blood vessel basement membrane
and are associated with the fibroblast-like cells. The latter
finding was unexpected since the laminin molecules are
known to be expressed by epithelial cells and there is no
organized basement membrane adjacent to fibroblasts.
Strong staining of the entire epidermis was observed only
with the anti-a4 LG1–3 antibody (Fig 1A(a)) and not with the
anti-a4 LG4–5 antibody (Fig 1A(d)).
We next analyzed whether human dermal fibroblasts
synthesized the laminin a4 chain. Western blot analysis of
conditioned media with anti-a4 LG1–3 antibody revealed a
major 175 kDa species and a minor 200 kDa species which
corresponds to the processed and unprocessed laminin a4
chains, respectively (Fig 1B, lane 2). Anti-a4 LG4–5 antibody
recognized a 200 kDa species corresponding to the
unprocessed laminin a4 chain (Fig 1B, lane 4). The laminin
a4 chain is a component chain of both laminin-8 (a4b1g1)
and laminin-9 (a4b2g1). Therefore, we also used an anti-
laminin g1 antibody for western blot of the conditioned
media. Anti-laminin g1 antibody recognized a 200 kDa
species (Fig 1B, lane 6). Under non-reducing conditions, the
bands containing processed and unprocessed laminin a4
chain migrated slower than the laminin a1 chain (about 400
kDa). These observations suggest that dermal fibroblasts
secrete a laminin heterotrimer containing a4 chains.
Cell adhesion activity of the laminin a4 LG4 module
Recombinant human laminin a4 chain LG4 module (rec-
LG4) was expressed in 293Tcells as a fusion protein with an
IgG Fc portion at the C-terminus. The purified rec-LG4 was
analyzed by SDS-PAGE and western blot and found to be
pure band with a predicted molecular weight of 60 kDa (Fig
2A). The rec-LG4 proteins were coated as substrates for cell
adhesion assays (Fig 2B). Dermal fibroblasts attached to
rec-LG4 in a concentration-dependent fashion. Cell adhe-
sion activity of rec-LG4 showed the maximum level at 0.2
mg per well and reached a plateau at more than 0.2 mg per
well. We next examined various glycosaminoglycans (GAGs)
as competitors for cell adhesion (Fig 2C). Fibroblast adhesion
to rec-LG4 was inhibited by heparin. HS weakly blocked
fibroblast attachment. No significant inhibition however was
observed with HA, CSA, DS, and CSC. These results
suggested that heparin and HS are involved in cell binding
to the laminin a4 LG4 module. As we used the same con-
centration of GAGs (250 mg per mL), the molar concentra-
tion of heparin to other GAGs ranged from about 1:1 to 1:10.
The inhibition assay with the lower concentration of heparin
(10 mg per mL) showed complete blockage of cell adhesion
to a4 LG4 and to HA4G82 (data not shown). The higher
concentration (250 mg per mL) was employed to obtain the
Figure1
Laminin a4 localization in the skin and its synthesis by dermal
fibroblasts. (A) Immunofluorescence staining of the laminin a4 chain in
adult human skin. Antibodies against a4 LG1–3 were used for (a–c).
Antibodies against a4 LG4–5 were used for (d–f ). In (a) and (d), there
was positive staining in the dermis. Positive signals were detected
surrounding fibroblast-like cells (b, e) and are located at blood vessel
walls (c, f ). Original magnification:  200 in (a, d) and  1000 in (b, c,
e, f ). (B) Conditioned media from human dermal fibroblasts were
applied on 5% SDS-PAGE, under reducing (lanes 2, 4, 6) or non-
reducing conditions (lanes 1, 3, 5), followed by western blotting. The
major band of 175 kDa in lane 2 is a processed laminin a4 chain. The
faint band () is an unprocessed a4 chain. In lane E, 4 mg of laminin-1
(a1b1g1) from EHS sarcoma was applied and stained by Coomassie
brilliant blue after blotting. a1, b1, and g1 and molecular size markers
are on the left side. The antibodies used are: lanes 1, 2, anti-a4LG1–3;
lanes 3, 4, anti-a4LG4–5; lanes 5, 6, anti-laminin g1 chain. 2ME (þ )
or () indicates the presence or absence of 2% mercaptoethanol,
respectively.
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inhibitory effect of HS in the cell adhesion assay (Utani et al,
2001). These data indicate that the higher potency observed
with heparin is based on charge density and not molar
concentration.
Identiﬁcation and characterization of the sequence
active for cell adhesion We prepared 19 synthetic pep-
tides covering the entire human LG4 module (Table I).
Peptides HA4G82, HA4G83, and HA4G90 strongly inhibited
fibroblast adhesion to rec-LG4, whereas the other synthetic
peptides showed no inhibition (Fig 3A). None of the three
peptides competed for fibroblast cell attachment to type I
collagen (data not shown). HA4G82, HA4G83, and HA4G90
were also active for cell attachment when they were coated
as substrates (Fig 3B). As expected, the rest of the peptides
did not promote fibroblast attachment (data not shown).
The activity of HA4G90 was much weaker than that of
HA4G82 and HA4G83. It was reported that the mouse a4
LG4 module has heparin-binding activity (Yamaguchi et al,
2000). The heparin-binding sequence of mouse a4 LG4
corresponds to the HA4G82 sequence of human a4 LG4.
Thus, we focused on HA4G82 as a critical sequence within
a4 LG4 since fibroblast adhesion to human a4 LG4 was
heparin-dependent. Cell adhesion to HA4G82 was inhibited
by heparin and HS, and not by other GAGs (Fig 3C). Since
heparin binds to basic residues, His and Arg residues were
substituted in the sequence TLFLAHGRLVFM with Ser
(HA4G82S: TLFLASGSLVFM). Dermal fibroblasts attached
to the HA4G82 but did not bind to the serine-substituted
peptide, HA4G82S (Fig 3D). Peptides HA4G82 strongly
inhibited fibroblast adhesion to rec-LG4, whereas HA4G82S
showed no inhibition activity (Fig 3D). These results
indicated that both the His and Arg residues within the
HA4G82 sequence, which are predicted to be essential for
heparin binding, were critical for the cell adhesion activity of
laminin a4 LG4.
293T cells overexpressing syndcan-2 and syndecan-4,
but not glypican-1, bind to laminin a4 LG4 The rec-LG4
protein and the HA4G82 peptide promoted the heparin- and
HS-dependent fibroblast attachment, suggesting that the
cell attachment is mediated by membrane-associated
heparan sulfate proteoglycans (HSPGs). Syndecans and
Figure 2
Heparin- and HS-dependent cell adhesion activity of the recombi-
nant a4 LG4 module. (A) Expression and purification of recombinant
a4 LG4 protein. Purified recombinant proteins were applied on 10%
SDS-PAGE. Under reducing condition lane 1, Coomassie brilliant blue
staining; lane 2, Western blotting. Molecular size markers are on the left
side. (B) Fibroblasts were seeded on different amounts of substrates,
including rec-LG4, control recombinant protein (rec-con, human
laminin g2 N-terminal 617 amino acids), and collagen I. The bound
cells were stained with crystal violet and the attached cells in three
randomly selected fields (  200) were counted. Each value represents
the mean  SD of triplicate experiments. (C) Fibroblasts were seeded
on rec-LG4 (0.2 mg per well) in the presence of 250 mg per mL of various
GAGs and attached cells were counted. The cell numbers without
competitors are taken as 100%. Each value represents the mean
 SD of four experiments. Hp, heparin; HA, hyaluronic acid; HS,
heparan sulfate; CSA, chondroitin sulfate A; DS, dermatan sulfate;
CSC, chondroitin sulfate C. Statistical analyses were performed using
an unpaired Student’s t test and depicts po0.01.
Table I. List of synthetic peptides
Peptide Sequencea
HA4G74 HLSNSPRAIEHA
HA4G75 IEHAYQYGGTAN
HA4G76 GTANSRQEFEHL
HA4G77 FEHLKGDFGAKS
HA4G78 GAKSQFSIRLRT
HA4G79 RLRTRSSHGMIF
HA4G82 TLFLAHGRLVYM
HA4G83 LVYMFNVGHKKL
HA4G84 HKKLKIRSQEKY
HA4G85 SQEKYNDGLWHD
HA4G86 LWHDVIFIRERS
HA4G87 RERSSGRLVIDG
HA4G88 VIDGLRVLEESL
HA4G89 LEESLPPTEATW
HA4G90 TEATWKIKGPIYL
HA4G91 GPIYLGGVAPGK
HA4G92 APGKAVKNVQIN
HA4G96 FEGPMETGTYFS
HA4G97 TYFSTEGGYVVL
HA4G82S TLFLASGSLVYM
aSequences of the synthetic peptides which covering entire human
laminin a4 chain LG4 module and HA4G82S is the serine substituted
peptide of HA4G82.
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glypican are well characterized as cell surface HSPGs.
Further, syndecan-2 and -4 are expressed in fibroblasts and
are known to be involved in cell adhesion. Therefore, we
focused on these molecules as candidates mediating cell
adhesion. Because 293T cells showed no adhesion activity
to rec-LG4 and HAG82, syndecan-2 and -4 were over-
expressed in 293T cells. Further, glypican-1, which is a cell
surface HSPG lacking a cytoplasmic domain, was also
stably expressed in 293Tcells. FACS analysis demonstrated
the levels of HS chains in the syndecan-2-, -4-, and
glypican-1-overexpressing 293T clones (Fig 4A). Synde-
can-2- and syndecan-4-overexpressing cells bound to rec-
LG4 and HAG4G82. In contrast, glypican-1-expressing cells
failed to bind to the substrates (Fig 4B). The HS level of the
glypican-1 clone was rather higher than that of syndecan-2
or -4 clones, indicating that the HS chain of glypican-1 is not
sufficient for cell adhesion to a4 LG4. Various GAGs as
competitive inhibitors were tested for their effects on cell
adhesion by the syndecan-2- and -4-expressing cells.
Attachment of both cell preparations to rec-LG4 and
HA4G82 was inhibited by heparin and HS. No significant
inhibition however was observed with other GAGs (Fig 4C,
D). Syndecan-2- and syndecan-4-expressing cells were
able to bind to HA4G82, but were not able to bind to
HA4G82S (Fig 4E). These results indicate that the rec-LG4
protein and the HA4G82 peptide specifically interact with
the HS chains of syndecan-2 and syndecan-4 and promote
cell attachment.
Discussion
Here, we have determined the location, function, and
cellular receptors of laminin a4 chain in the skin. Our
immunofluorescence study demonstrated that processed
and unprocessed laminin a4 chains are located in the
basement membrane zone of capillary vessels and in an
area adjacent to fibroblast-like cells. The numbers of
positively stained capillary vessels and fibroblast-like cells
are similar to either anti-LG4–5 or anti-LG1–3. In contrast,
anti-LG4–5 could not detect the laminin a4 chain in other
tissues, such as capillary walls, adipose, and neural tissues
(Talts et al, 2000). These results indicate that the degree of
processing of the a4 chain is different in the distinct tissues
where it is located. It was unexpected that fibroblast-like
cells had a positive signal for the laminin a4 chain. An
electron microscopic study showed that the laminin a4
chain was not a constituent of endothelial basement
membrane but was deposited in adjacent extracellular
regions (Talts et al, 2000). The laminin a4 chain surrounding
dermal fibroblasts may have a new function. Previously,
molecules recognized by anti-EHS laminin antibody (lami-
nin-1, a1b1g1) were found in fibroblast conditioned media
(Woodley et al, 1988). Furthermore, to verify the presence of
a laminin trimer with the laminin a4 chain in fibroblast-like
cells, we performed western blotting. By reverse transcrip-
tase-PCR, mRNA expression of laminin a4 and b1, 2, 3, and
g1 was also detected (data not shown). Therefore, it is
possible that laminin-8 (a4b1g1) and/or -9 (a4b2g1) is
produced by dermal fibroblasts. Thus, fibroblasts may
synthesize and secrete laminin-8 and/or -9, which are
present in the adjacent matrix.
Previously, we identified several active sites within the
mouse a4 LG1–5 module for cell adhesion (Okazaki et al,
2002). HA4G82 corresponds to the mouse sequence
TLFLAHGRLVFM, which is one of the active sites with
heparin-dependent cell adhesion ability. The basic residues
His and Arg in HA4G82, which were verified to be essential
for cell adhesion by serine substitution in this report, are
conserved between human and mouse. To identify the
cell adhesion receptor for the sequence within HA4G82,
we utilized 293T cells overexpressing syndecans for cell
adhesion. Our data clearly demonstrate that syndecan-2
and -4 bind to a4 LG4 and function as adhesion receptors.
We analyzed the cell surface HSPG by FACS analysis. The
level of HSPG in glypican-1-overexpressing cells is higher
than that in syndecan-2 or –4 overexpressing cells; how-
ever, the glypican-1-overexpressing cells failed to attached
Figure 3
Effect of synthetic peptides on cell adhesion to the recombinant a4
LG4 module and cell attachment activity of the peptides. (A) 96-well
microplates were coated with 0.2 mg per well of rec-LG4. The synthetic
peptides (100 mg per mL) were added to wells with the cells during the
incubation. (B) Fibroblasts were seeded on different amounts of the
substrates, HA4G82, HA4G83, and HA4G90. (C) Fibroblasts were
seeded on HA4G82 (3.8 mg per mL) in the presence of 250 mg per mL of
various GAGs. (D) Adhesion to HA4G82 and to HA4G82S (5 mg per well)
was determined (columns 1, 2). The inhibition assay was performed
using 0.5 mg per well of rec-LG4 (columns 3–5). HA4G82 and HA4G82S
(100 mg per mL) were added to the wells with the cells during the
incubation. The cell numbers without competitors are taken as 100%
(A, C, columns 3–5 in D). In columns 1, 2 in (D), the cell numbers
attached to the HA4G82 are taken as 100%. The bound cells were
stained with crystal violet and the attached cells in randomly selected
three fields (  200) were counted. Each value represents the mean
 SD of multiple independent experiments. depicts po0.01 in (C)
and (D).
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to a4 LG4. This observation confirmed that the interaction of
the HS chain and laminin a4 LG4 module is necessary but
not sufficient for cell adhesion. The protein core sequence
is also probably required for this interaction. The well-
conserved cytoplasmic domain in syndecans is probably
required for mediating the signal from the cell surface LG4–
syndecan interaction to the intracellular events.
Recently, analysis with a4-null mouse demonstrated that
the a4 chain played a central role in microvessel growth
(Thyboll et al, 2002). In the syndecan-4 null mouse, skin
wounds showed delayed healing and impaired capillary
proliferation compared with that of the wild-type mouse
(Echtermeyer et al, 2001). Therefore, our observations
suggest that cell adhesion to the laminin a4 LG4 module
through syndecans may be important in angiogenesis in
wounded skin. A precise understanding of the mechanisms
of the signaling pathway from a4 LG4 binding to syndecan
may contribute to clinical applications for the treatment of
chronic cutaneous wounds.
Materials and Methods
Antibodies Anti-a4 LG1–3 and a4 LG4–5 antibodies were gifts
of Dr Timpl (Max-Planck-Institut fu¨r Biochemie, Martinsried, Ger-
many) (Talts et al, 2000). Fluorescein isothiocyanate (FITC)-
conjugated anti-rabbit IgG antibody was purchased from Jackson
ImmunoResearch Laboratories (West Grove, Pennsylvania). Anti
laminin g-1 polyclonal antibodies (H-190) were obtained from
Santa Cruz Biotechnology (Santa Cruz, California). FITC-conju-
gated anti-heparan sulfate (HS) (10E4) monoclonal antibody
(mouse IgM, k) (Seikagaku, Tokyo, Japan) and isotype antibody,
FITC, mouse IgM, k, isotype standard (anti-TNP) (PharMingen, San
Diego, CA), were used for FACS analysis.
Cultured cells Human neonatal dermal fibroblasts were obtained
from Asahi Techno Glass (Tokyo, Japan). Fibroblasts were main-
tained in Dulbecco’s MEM (DMEM, Invitrogen Life Technologies,
Carlsbad, California) supplemented with 10% fetal bovine serum
(FBS, Invitrogen Life Technologies), 100 U per mL penicillin, and 50
U per mL streptomycin. 293T cell clones producing syndecan-2,
-4, and glypican-1 were maintained with 0.4 mg per mL of puro-
mycin (Sigma)/10%FBS/DMEM as previously described (Utani
et al, 2001).
Immunoﬂuorescence Frozen sections of adult human skin,
obtained with informed consent, were air dried for 15 min at room
temperature, washed with phosphate-buffered saline (PBS) for
15 min, and blocked with 5% normal donkey serum (Chemicon
International, Temecula, California)/1% bovine serum albumin
(BSA)/0.05% NP-40 (Sigma Chemical, St Louis, Missouri)/PBS
for 15 min. Sections were incubated with either anti-a4 LG1–3 or
a4 LG4–5 antibodies (1:100) overnight at 41C, and followed by
FITC-conjugated anti-rabbit IgG antibody (1:200) for 30 min at
371C. The specimens were analyzed by a Zeiss immunofluore-
sence microscope.
Figure4
Syndecan-2- and syndecan-4-, but not glypican-1-, overexpressing
293T cells adhere to recombinant a4 LG4 and HA4G82. (A) FACS
analysis with 10E4 monoclonal antibody for HS of the parental 293T
cells and 293T cells overexpressing syndecan-2 (Syn-2), syndecan-4
(Syn-4), and glypican-1 (GP-1). The solid lines represent the basal level
of HS in the parental 293T cells and the gray areas represent HS
fluorescence in the 293T cells. (B) Syn-2, Syn-4, and GP-1 cells, and
parental 293T cell adhesion to either rec-LG4 (0.6 mg per well) or
HA4G82 (15 mg per well). (C, D) Syn-2 and Syn-4 were seeded on rec-
LG4 (C) or HA4G82 (D) in the presence of 250 mg per mL of various
GAGs. Hp, heparin; HA, hyaluronic acid; HS, heparan sulfate; CSA,
chondroitin sulfate A; DS, dermatan sulfate; CSC, chondroitin sulfate C.
(E) Syn-2 and Syn-4 adhesion to HA4G82 and its serine-substituted
analog HA4G82S (15 mg per well). In these experiments, the attached
cells in three randomly selected fields (  200) were counted. The cell
numbers without competitors are taken as 100% (C, D). Each value
represents the mean  SD of three experiments. depicts po0.01 in
(C) and (D).
618 MATSUURA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Western blotting For western blotting, conditioned media were
collected from fibroblasts in a 75 cm2 flask after a 24 h incubation
with DMEM. The media were extensively dialyzed against distilled
water, lyophilized, and dissolved in 50 mL of sample buffer (20%
glycerol, 2% SDS, 125 mM Tris-HCl, pH 6.8, 2% mercaptoethanol,
and 0.15% bromophenol blue), and 20 mL of sample was
separated on 5% SDS-PAGE and transferred by electroblotting
onto PVDF transfer membranes (Immobilon, Millipore, Bedford,
Massachusetts). The membranes were blocked with 10% non-fat
milk in Tris-buffered saline (150 mM NaCl, 40 mM Tris-HCl, pH 7.4)
with 0.1% Tween-20, probed with the first antibodies (1:200), and
visualized by alkaline phosphatase-conjugated anti-rabbit IgG
antibody (Jackson ImmunoResearch Laboratories) and 5-bromo-
4-chloro-3-indolyl phosphatate/nitro blue tetrazolium (BCIP/NBT)
(Moss, Pasadena, Maryland). Mouse laminin-1 from EHS sarcoma
was a gift from Dr Kleinman (NIDCR, NIH, Bethesda, Maryland).
For western blotting with anti-laminin g1 chain antibody, perox-
idase-conjugated anti-rabbit IgG antibody and ECL (Amersham-
Pharmacia Biotech, Uppsala, Sweden) were used.
Recombinant a4 LG4 module expression cDNA was synthe-
sized using mRNA from human fibroblasts prepared using the
Superscript Preamplification System (Invitrogen Life Technologies)
and amplified using the Expand High Fidelity PCR System (Roche
Diagnostics, Basel, Switzerland). After amplification, the PCR
product was cut with Avr II, and cDNA was inserted into a MO90
vector, which expresses a signal peptide and a human IgG Fc
portion under the EF1-a promoter. All constructs were confirmed
by DNA sequencing using a thermo-sequence Cy5 dye terminator
and an ALF express II DNA sequencer (Amersham Pharmacia
Biotech). The primers for RT-PCR were as follows: rec-LG4 (4060–
4640 nt of human laminin a4 chain, GenBanK: #11418562), forward
50-GAGCCTAGGCCACCTTTCCAACAGCCCTAG-30 and backward
50-GAGCCTAGGCCCACGTATCCTCCTCCTGTT-30. Recombinant
a4 LG4 was expressed as a chimera with a human IgG Fc portion
at the C-terminus and purified as previously described with a minor
modification (Utani et al, 2001). Briefly, recombinant proteins were
expressed in 293Tcells by the Ca-P Transfection Kit (Invitrogen Life
Technologies). After 24 h, cells were incubated with CHO medium
(Invitrogen Life Technologies) for another 2 days, followed by
purification with protein A–sepharose (Amersham-Pharmacia Bio-
tech). The protein concentration was calculated with the BCA
Protein Assay Kit (Pierce, Rockford, Illinois). Protein purity was
determined by reducing 10% SDS-PAGE and Coomassie brilliant
blue staining.
Synthesis of human laminin a4 LG4 peptides Peptides com-
prising the human a4 LG4 module were manually synthesized by
the 9-fluorenylmethoxycarbonyl (Fmoc)-based solid-phase method
with a C-terminal amide as previously described (Utani et al, 2001).
Peptides were purified by reverse-phase high-performance liquid
chromatography (HPLC) using a Mightysil RP-18 column (Kanto
Chemical, Tokyo, Japan) with a gradient of water/acetonitrile
containing 0.1% trifluoroacetic acid. Purity and identity were
confirmed by HPLC and by fast atom bombardment mass spectral
analysis at the GC-MS & NMR Laboratory, Graduate School of
Agriculture, Hokkaido University.
Cell adhesion assays Substrates included collagen I (Nitta
gelatin, Tokyo, Japan), recombinant a4 LG4, human laminin g2
N-terminal 617 amino acids as a negative control recombinant
protein (Utani et al, 2001), and synthetic peptides. 96-well plates
(Nalge Nunc International, Rochester, New York) were coated
with recombinant proteins and collagen substrates in distilled
water overnight at 41C. Peptide substrates were air dried at
room temperature. The wells were rinsed with distilled water, and
blocked with 1% BSA (Sigma)/DMEM for 1 h at room temperature.
Cells were trypsinized and recovered in 10% FBS/DMEM for
30 min at 371C in 5% CO2 in a humidified atmosphere followed
by three rinses with 0.1% BSA/DMEM. Then, 100 mL of the cell
suspension (2  105 per mL) in 0.1% BSA/DMEM was plated on
the wells for 1 h at 371C in 5% CO2 in a humidified atmosphere.
The wells were rinsed once with PBS and stained with 0.1% crystal
violet in 20% methanol (v/v) for 10 min. The attached cells in three
randomly selected fields (  200) were counted. For competition
assays, cells were preincubated for 10 min at room temperature
with either synthetic peptides, or 250 mg per mL of heparin (Hep),
heparan sulfate (HS), chondroitin sulfate A (CSA), dermatan sul-
fate (DS), chondroitin sulfate C (CSC), or hyaluronic acid (HA)
(Seikagaku Kogyo, Tokyo, Japan) and used for the cell adhesion
assay as above. Only soluble peptides were assayed in these
experiments. The molecular weights of GAGs used in this ex-
periments are 10–20K (Hep), 11K (HS), 25–50K (CSA), 11–25K (DS),
40–80K (CSC), and 100–200K (HA).
FACS analysis Monolayer cells were harvested by PBS contain-
ing 0.53 mM EDTA, re-suspended in 10%FBS/DMEM. Cells
(5  105 per sample) were stained with 20 mg per mL FITC-
conjugated anti HS (10E4) monoclonal antibody in 1% BSA/PBS.
After a 30 min incubation on ice, cells were washed. Flow
cytometry analysis was performed on a FACScaliber (Becton
Dickinson, Franklin Lakes, NJ), and results were analyzed with
CELLQuest software (Becton Dickinson). A 2 mg per mL propidium
iodide solution was used to determine the population of dead cells.
Control staining was performed using isotype-matched antibody
(anti-TNP) and there was no significant background staining with
10E4 monoclonal antibody (data not shown).
Statistical analyses Statistical analyses were performed using an
unpaired Student’s t test with StatView J., Hulinks, Tokyo, Japan.
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